References [1]  Pan XF, Wang L, Pan A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol 2021; 9: 373–92. [2]  Institute ...

Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be ...

Absci has entered the clinic with its AI-designed antibody, dosing first volunteers in a trial targeting TL1A for ...

Innovent announces phase 3 study of mazdutide in Chinese adults with overweight or obesity (GLORY-1) published in the NEJM: San Francisco, US Tuesday, May 27, 2025, 11:00 Hrs [IST ...

ANI Pharma initiates phase 4 trial of purified Cortrophin Gel to treat acute gout flares: Princeton, New Jersey Friday, May 23, 2025, 14:00 Hrs [IST] ANI Pharmaceuticals, Inc., a ...

Rocket Pharmaceuticals shares plummeted 60% Tuesday after the firm said it halted a study of a gene-therapy drug for Danon ...

Mazdutide is expected to launch in China this year, with anticipated approvals for weight management and glycemic control.

A phase 3 trial found that ubrogepant, given during the premonitory phase of migraine, improved common warning symptoms such as fatigue, light and sound sensitivity, and neck pain. These benefits were ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Clinical trials, traditionally plagued by low success rates and high operational costs, are being reengineered through AI ...

Capricor Therapeutics is seeking FDA approval for CAP-1002, targeting heart function in Duchenne Muscular Dystrophy patients.